Rising Medicare exit rates among physicians, especially primary care, highlight growing dissatisfaction and administrative ...

Jeremiah Johnson, executive director of PrEP4All, an organization committed to HIV prevention and care, talks about the ...

Two PBMs, True Rx Health Strategies and Capital Rx, are using pharmacogenomics — how a person’s DNA affects their response to ...

Proposed Medicaid changes could lead to 1,500 excess deaths and $135 billion in economic losses annually, impacting health care and rural communities.

In this interview, Sarah Morris, chief product officer of Audere, explains why they chose to focus on women and young girls ...

Health policy researcher Geoffrey Joyce argues that only delinking compensation from the list price of a drug will lower drug ...

The FDA has accepted the resubmitted BLA for tabelecleucel (tab-cel), intended for the treatment of Epstein-Barr virus ...

Managed Healthcare Executive gives C-suite executives in health plans and provider organizations news and strategies for value-driven solutions.

Last week, an FDA advisory committee against the risk-benefit profile of Blenrep in combination with other therapies. Regulators and reviewers were concerned about the ocular side effects and dosing ...

BioMarin's Roctavian gene therapy shows long-term effectiveness in treating severe hemophilia A, reducing bleeding and ...

Replimune's RP1 treatment for advanced melanoma faces FDA rejection due to trial design issues, despite promising results ...

Humana has released details about additional, upcoming organizational improvements to encourage a faster prior authorization ...